ArticleVaccines2025

Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico.

José Luis Huerta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.